Thomas R. Cannell - President and CEO, Director at Carisma Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
CARM on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Thomas R. Cannell since 11/12/2023

Holdings reported by Thomas R. Cannell for Carisma Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 672K $395K $0.59 Mar 2, 2023 Direct

Transactions reported by Thomas R. Cannell for Carisma Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.